Literature DB >> 20060371

Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases.

Daniela Cabibi1, Giuseppe Tarantino, Francesco Barbaria, Maria Campione, Antonio Craxì, Vito Di Marco.   

Abstract

BACKGROUND/AIM: Plasma cells infiltrate in the liver is a prototype lesion of autoimmune liver diseases. The possible role of plasma cells isotyping (IgM and IgG) in the liver in the diagnostic definition of autoimmune liver disease, and particularly in variant syndromes such as autoimmune cholangitis and the primary biliary cirrhosis/autoimmune hepatitis overlap syndrome, is less defined.
METHODS: We analysed the clinical, serological and histological features of 83 patients with autoimmune liver disease (40 primary biliary cirrhosis, 20 autoimmune hepatitis, 13 primary sclerosing cholangitis, 4 autoimmune cholangitis and 6 overlap syndrome) compared to 34 patients with chronic hepatitis C and evaluated the expression of IgM and IgG plasma cells in their liver by immunostaining.
RESULTS: By Spearman's correlation, the mean-counts of IgM plasma cells in portal tracts were significantly correlated with female gender, serum alkaline phosphatase, gamma-glutamyl transferase and IgM values, positivity for anti-mitochondrial antibody-M2 and, on liver biopsy, with bile duct changes, orcein-positive granules and granulomas. Whereas IgG plasma cells resulted more correlated with alanine aminotransferase levels. IgG/IgM ratio lower than 1 was found no only in primary biliary cirrhosis but also in all patients with autoimmune cholangitis. Conversely, all patients with overlap syndrome showed IgG/IgM ratio higher than 1.
CONCLUSION: Immunostaining for IgM and IgG plasma cells on liver tissue can be a valuable parameter for better diagnosis of autoimmune liver disease and also for variant or mixed syndromes. Copyright 2009 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060371     DOI: 10.1016/j.dld.2009.12.006

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  9 in total

Review 1.  Autoimmune hepatitis.

Authors:  Farhad Sahebjam; John M Vierling
Journal:  Front Med       Date:  2015-03-06       Impact factor: 4.592

2.  Involvement of (IgG and IgM)-secreting B lymphocytes in severity of autoimmune hepatitis type 1.

Authors:  Ayaid Khadem Zgair
Journal:  Med Microbiol Immunol       Date:  2013-01-08       Impact factor: 3.402

3.  Primary biliary cirrhosis and hereditary hemorrhagic telangiectasia: When two rare diseases coexist.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Nicola Alessi; Giuseppe Cabibbo; Daniela Cabibi
Journal:  World J Hepatol       Date:  2013-05-27

4.  The utility of IgG, IgM, and CD138 immunohistochemistry in the evaluation of autoimmune liver diseases.

Authors:  Kazumichi Abe; Atsushi Takahashi; Yoshihiro Nozawa; Hiromichi Imaizumi; Manabu Hayashi; Ken Okai; Yukiko Kanno; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Med Mol Morphol       Date:  2014-06-27       Impact factor: 2.309

Review 5.  The overlap syndromes of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

6.  Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis.

Authors:  Mio Kobayashi; Yuko Kakuda; Kenichi Harada; Yasunori Sato; Motoko Sasaki; Hiroko Ikeda; Mitsuhiro Terada; Munenori Mukai; Shuichi Kaneko; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 7.  Diagnosis and treatment of autoimmune hepatitis.

Authors:  John M Vierling
Journal:  Curr Gastroenterol Rep       Date:  2012-02

8.  Low incidence of positive smooth muscle antibody and high incidence of isolated IgM elevation in Chinese patients with autoimmune hepatitis and primary biliary cirrhosis overlap syndrome: a retrospective study.

Authors:  Pan Zhao; Yukun Han
Journal:  BMC Gastroenterol       Date:  2012-01-03       Impact factor: 3.067

9.  Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease.

Authors:  Brian K Chung; Eva Kristine Klemsdal Henriksen; Kristin Kaasen Jørgensen; Tom H Karlsen; Gideon M Hirschfield; Evaggelia Liaskou
Journal:  Hepatol Commun       Date:  2018-08-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.